Neumora Therapeutics is a clinical-stage biotechnology company focused on developing neuroscience drugs.

Register for Details

For more details on financing and valuation for Neumora, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Neumora's ticker symbol?


What is Neumora's stock price?

11.4 as of 9/25/23

Neumora Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
10/11/2022 Series B $112.4MM raised $XXX.XX $XXX.XX
10/7/2021 Series A-1 and A-2 $500MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Neumora

Forge green plus iconForge green minus icon

What is Neumora funding to date?

Neumora has raised $612.4MM to date.
Forge green plus iconForge green minus icon

When was Neumora founded?

Neumora was founded in 2019.
Updated on: Jun 12, 2022